Minerva Neurosciences Inc (NERV)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NERV market cap is 15.39M. The company's latest EPS is USD -4.2905 and P/E is -0.51.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.52M | -6.08M | -7.17M | -6.68M | -6.28M |
| Net Income | -6.19M | -7.82M | -9.02M | -8.57M | -8.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 41.18M | 0 | 0 | 0 |
| Operating Income | -75.87M | 1.85M | -45.37M | -25.23M | -23.12M |
| Net Income | -72.18M | 1.94M | -49.91M | -32.11M | -30.01M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 67.14M | 63.13M | 56.9M | 50.51M | 46.29M |
| Total Liabilities | 79.65M | 83.18M | 85.36M | 87.1M | 90.78M |
| Total Equity | -12.51M | -20.05M | -28.46M | -36.59M | -44.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 77.5M | 57.63M | 77.12M | 55.09M | 56.9M |
| Total Liabilities | 49.72M | 4.96M | 69.15M | 75.11M | 85.36M |
| Total Equity | 27.78M | 52.66M | 7.98M | -20.02M | -28.46M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.99M | -8.79M | -14.79M | -6.1M | -10.03M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 19.69M | 19.6M | 19.6M | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.43M | -33.82M | -24.6M | -24.65M | -14.79M |
| Investing | 14.09M | 24.53M | N/A | -16k | N/A |
| Financing | 525k | 13.24M | 60M | N/A | 19.6M |
| Market Cap | 15.39M |
| Price to Earnings Ratio | -0.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.38 |
| Price to Book Ratio | -0.54 |
| Dividend Yield | - |
| Shares Outstanding | 6.99M |
| Average Volume (1 week) | 11.36k |
| Average Volume (1 Month) | 25.5k |
| 52 Week Change | -53.58% |
| 52 Week High | 13.49 |
| 52 Week Low | 2.2001 |
| Spread (Intraday) | 4.16 (67.64%) |
| Company Name | Minerva Neurosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.minervaneurosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
